We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Faraday Pharmaceuticals Stock

Invest in or calculate the value of your shares in Faraday Pharmaceuticals or other pre-IPO companies through EquityZen's platform.

Get Started

Faraday Pharmaceuticals Stock (FAPH)

Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.

About Faraday Pharmaceuticals Stock

Founded

2014

Headquarters

Seattle, WA, US

Industries

Software, Artificial Intelligence, Data and Analytics

Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury. It has in-licensed proprietary liquid formulations of reduced nonmetal gaseous elements developed in the lab of Dr. Mark Roth at the Fred Hutchinson Cancer Center. The company was founded in 2014 and is located in Seattle, Washington.

Faraday Pharmaceuticals Management

Leadership team at Faraday Pharmaceuticals

CEO

Stephen A. Hill

General Counsel & Corporate Secretary

Patrick C. Rock

Locked Features

Join now and verify your accreditation status to gain access to:

  • Faraday Pharmaceuticals current valuation
  • Faraday Pharmaceuticals stock price
  • Available deals in Faraday Pharmaceuticals and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Faraday Pharmaceuticals stock?

Accredited investors can buy pre-IPO stock in companies like Faraday Pharmaceuticals through EquityZen funds. These investments are made available by existing Faraday Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Faraday Pharmaceuticals stock?

Shareholders can sell their Faraday Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."